Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Time to Consultation and Disease-modifying Antirheumatic Drug Treatment of Patients with Rheumatoid Arthritis — Northern Alberta Perspective

JALAL A. NANJI, MAY CHOI, ROBERT FERRARI, CHRISTOPHER LYDDELL and ANTHONY S. RUSSELL
The Journal of Rheumatology April 2012, 39 (4) 707-711; DOI: https://doi.org/10.3899/jrheum.110818
JALAL A. NANJI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAY CHOI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT FERRARI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rferrari{at}shaw.ca
CHRISTOPHER LYDDELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTHONY S. RUSSELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Nell VPK,
    2. Machold KP,
    3. Eberl G,
    4. Stamm TA,
    5. Uffmann M,
    6. Smolen JS
    . Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004;43:906–14.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. van der Linden MP,
    2. le Cessie S,
    3. Raza K,
    4. van der Woude D,
    5. Kneyel R,
    6. Huizinga TW,
    7. et al.
    Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 2010;62:3537–46.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Lacaille D,
    2. Anis AH,
    3. Guh DP,
    4. Esdaile JM
    . Gaps in care for rheumatoid arthritis: A population study. Arthritis Rheum 2005;53:241–8.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Qian J,
    2. Ehrmann Feldman D,
    3. Bissonauth A,
    4. Menard HA,
    5. Panopalis P,
    6. Stein M,
    7. et al.
    A retrospective review of rheumatology referral wait times within a health centre in Quebec, Canada. Rheumatol Int 2010;30:705–7.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Yelin EH,
    2. Such CL,
    3. Criswell LA,
    4. Epstein WV
    . Outcomes for persons with rheumatoid arthritis with a rheumatologist versus a non-rheumatologist as the main physician for this condition. Med Care 1998;36:513–22.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Combe B,
    2. Landewe R,
    3. Lukas C,
    4. Bolosiu HD,
    5. Breedveld F,
    6. Dougados M,
    7. et al.
    EULAR recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34–45.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. ACR Subcommittee on rheumatoid arthritis guidelines
    . Guidelines for the management of rheumatoid arthritis, 2002 update. Arthritis Rheum 2002;46:328–46.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Kiely P,
    2. Williams R,
    3. Walsh D,
    4. Young A
    . Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: The ERAS cohort. Rheumatology 2009;48:57–60.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Jamal S,
    2. Alibhai SMH,
    3. Badley E,
    4. Bombardier C
    . Time to treatment for new rheumatoid arthritis in a major metropolitan city. J Rheumatol 2012. [in press]
  10. 10.↵
    1. Shipton D,
    2. Glazer RH,
    3. Guan J,
    4. Badley EM
    . Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population. Med Care 2004;42:901–13.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Feldman DE,
    2. Bernatsky S,
    3. Haggerty J,
    4. Lefondre K,
    5. Tousignant P,
    6. Roy Y,
    7. et al.
    Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: A population-based study. Arthritis Rheum 2007;57:1419–25.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Bernatsky S,
    2. Feldman DE,
    3. Shrier I,
    4. Toupin K,
    5. Haggerty J,
    6. Tousignant P,
    7. et al.
    Care pathways in early rheumatoid arthritis. Can Fam Physician 2006;52:1444–5.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Gabriel S
    . The sensitivity and specificity of computerized databases for the diagnosis of rheumatoid arthritis. Arthritis Rheum 1994;37:821–3.
    OpenUrlPubMed
  14. 14.↵
    1. Emery P,
    2. Breedveld FC,
    3. Dougados M,
    4. Kalden JR,
    5. Schiff MH,
    6. Smolen JS
    . Early referral recommendation for newly diagnosed rheumatoid arthritis: Evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290–7.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Fitzgerald A,
    2. De Coster C,
    3. McMillan S,
    4. Naden R,
    5. Armstrong F,
    6. Barber A,
    7. et al.
    Relative urgency for referral from primary care to rheumatologists: the Priority Referral Score. Arthritis Care Res 2011;63:231–9.
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 39, Issue 4
1 Apr 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Time to Consultation and Disease-modifying Antirheumatic Drug Treatment of Patients with Rheumatoid Arthritis — Northern Alberta Perspective
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Time to Consultation and Disease-modifying Antirheumatic Drug Treatment of Patients with Rheumatoid Arthritis — Northern Alberta Perspective
JALAL A. NANJI, MAY CHOI, ROBERT FERRARI, CHRISTOPHER LYDDELL, ANTHONY S. RUSSELL
The Journal of Rheumatology Apr 2012, 39 (4) 707-711; DOI: 10.3899/jrheum.110818

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Time to Consultation and Disease-modifying Antirheumatic Drug Treatment of Patients with Rheumatoid Arthritis — Northern Alberta Perspective
JALAL A. NANJI, MAY CHOI, ROBERT FERRARI, CHRISTOPHER LYDDELL, ANTHONY S. RUSSELL
The Journal of Rheumatology Apr 2012, 39 (4) 707-711; DOI: 10.3899/jrheum.110818
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Congruence Between Child Self-Reported and Caregiver-Proxy–Reported Health-Related Quality of Life in Children With Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus
  • A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus
  • Comorbidity Development and Mortality During 10 Years of Follow-up in a Danish Nationwide Cohort of 3178 Patients With Systemic Lupus Erythematosus
Show more Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire